☆ 4.5 Article

Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13

BLOOD CANCER JOURNAL (2021)

Get Full Text
Add to Collection

Journal

BLOOD CANCER JOURNAL
Volume 11, Issue 1, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41408-020-00398-9

Keywords

-

Categories

Oncology Hematology

Funding

  1. National Institutes of Health Specialized Programs of Research Excellence (SPORE) [P50100707, R01CA207237, PO1 CA155258, RO1 CA050947]
  2. Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  3. Riney Family Multiple Myeloma Initiative

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.